General MedicationsORALStandard
RISPERIDONE
RISPERIDONE
Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview RISPERIDONE is listed in Drugs@FDA under application 205104 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient RISPERIDONE Form and strength TABLET;ORAL - 3MG Sponsor IPCA LABS LTD Submission history Latest submission status date: 2025-04-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview RISPERIDONE is listed in Drugs@FDA under application 205104 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RISPERIDONE Form and strength TABLET;ORAL - 3MG Sponsor IPCA LABS LTD Submission history Latest submission status date: 2025-04-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.